Societe Generale Starts Novo Nordisk (NVO) at Sell
Tweet
Share
E-mailGet Alerts NVO Hot Sheet
Price: $45.33 -0.61%
Rating Summary:
8 Buy, 17 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Rating Summary:
8 Buy, 17 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Join SI Premium – FREE
Societe Generale initiated coverage on Novo Nordisk (NYSE: NVO) with a Sell rating.
For an analyst ratings summary and ratings history on Novo Nordisk click here. For more ratings news on Novo Nordisk click here.
Shares of Novo Nordisk closed at $55.35 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novo Nordisk seeks China approval for oral Wegovy drug
- Evercore ISI Starts Red Cat Holdings Inc. (RCAT) at Outperform, PT $15, 'Ready. Set. Fly.'
- Deutsche Bank Starts Dell (DELL) at Hold
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
